About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
Our group is dedicated to paediatric research. We are interested in rare respiratory and endocrinological diseases, and also in common paediatric problems such as normal growth, asthma, neonatal pathology and imaging diagnosis, as well as minority diseases. Our goal is to transfer the findings of clinical and genetic studies to the widespread clinical practice and the general population, with the long-term objective of obtaining better diagnoses, implementing better therapeutic practices and improving the health of children.
Our group is part of CIBERER (Biomedical Research Networking Centre on Rare Diseases) (CIBERER U712) and European Reference Networks (ERN) for rare diseases ERN LUNG and Endo-ERN.
Asthma and recurrent wheezing: Inflammatory markers. Insight into its pathogenesis and treatment.
Infant and children lung function: Reference values and clinical application.
IP: Antonio Moreno Galdó, Inés de Mir Messa
We have created and are implementing and evaluating the outcomes of an educational program to treat paediatric obesity (Niñ@s en Movimiento®).
IP: Diego Yeste Fernandez
Our paediatric Cystic Fibrosis Unit is one of the most important in Spain regarding number of patients and clinical research. We are the only centre in Spain collaborating in the European Cystic Fibrosis Clinical Trial Network, and in the Cystic Fibrosis Core Network of ERN-Lung. Besides clinical investigation, we are working in translational lab projects in collaboration with the Genetic Medicine group to study the role of the eicosanoid pathway in the lung inflammation of this patients and, more importantly, to personalise the treatments for cystic fibrosis patients through the implementation of primary cultures of epithelial cells (bronchial, nasal) and organoids (rectal epithelium) and the study of transcripts and genomics by next generation sequencing in clinically diagnosed CF patients but with incomplete genomic characterization.
IP: Silvia Gartner Tizzano
4.1 Disorders of sex development (DSD): clinical and molecular diagnosis. We analyse known genes involved in human sexual differentiation and search for new genes.
4.2 Program of molecular diagnosis of thyroid dyshormonogenesis in patients with hypothyroidism which have been diagnosed at the newborn screening program. The objective of this project is to advance in the identification and characterization of the molecular basis of the patients with thyroid dyshormonogenesis through the implementation of next generation sequencing techniques (NGS) to later translate these results to the routine diagnosis of the detected patients in the program of Neonatal Screening of Congenital Hypothyroidism. Our group is reference centre for Catalonia. 4.3 Familial isolated glucocorticoid deficiency: clinical and molecular diagnosis. We analyse known genes involved in familial isolated glucocorticoid deficiency and search for new genes.
4.4 Congenital hyperinsulinism: clinical and molecular diagnosis. We analyse known genes involved in congenital hyperinsulinism and search for new genes.
IP: Diego Yeste Fernandez, Maria Clemente Leon, Monica Fernandez Cancio
IP: Maria Clemente Leon Collaborators: María Antolín Mate, Diego Yeste Fernandez, Nuria Gonzalez Llorens, Ariadna Campos Martorell, Cristina Aguilar Riera, Eduard Mogas Viñas Funding agency: Instituto de Salud Carlos III Funding: 106250 Reference: PI24/01376 Duration: 01/01/2025 - 31/12/2027
IP: Nerea Maiz Elizaran Collaborators: Josefa Élida Vázquez Méndez, Marta Codina Solà, Ma Irene Valenzuela Palafoll, Silvia Arévalo Martínez, Carlota Rodó Rodríguez, Eulàlia Rovira Moreno, David Gómez Andrés, Amaia Lasa Aranzasti, Elena Moreno Perez Funding agency: Fundació La Marató de TV3 Funding: 197000 Reference: 202420-10 Duration: 20/02/2025 - 19/02/2028
IP: Anna Gros Turpin Collaborators: Laura Gonzalez Garcia, Patricia Rubio Garrido, Raquel Rodríguez Gil, Javier Garcia Fernandez, Pablo Buck Sainz Funding agency: Col·legi Oficial d'Infermers/es de Barcelona Funding: 5830 Reference: PR-730/2024 Duration: 01/01/2025 - 31/12/2026
IP: Maria Creu Regne Alegret Collaborators: Antonio Moreno Galdó, Mª Angeles Aceituno López, María Nieves Pelay Planes, Esperanza Zuriguel Pérez, Ester Navarro Correal Funding agency: Col·legi Oficial d'Infermers/es de Barcelona Funding: 6490 Reference: PR-613/2023 Duration: 01/01/2024 - 31/12/2025
PhD student: Noelia Baz Redón Director/s: Nuria Camats Tarruella, Antonio Moreno Galdó University: Universitat Autònoma de Barcelona Year: 2022
PhD student: Alba Torrent Vernetta Director/s: Antonio Moreno Galdó University: Universidad Autònoma de Barcelona Year: 2021
PhD student: Laura Soler Colomer Director/s: Diego Yeste Fernandez University: Universidad Autònoma de Barcelona Year: 2020
PhD student: Sandra Rovira Amigo Director/s: Antonio Moreno Galdó University: Universidad Autònoma de Barcelona Year: 2020
PhD student: Angela Gregoraci Fernández Director/s: Félix Castillo Salinas University: Universidad Autònoma de Barcelona Year: 2019
PhD student: Ferran Rosés i Noguer Director/s: Antonio Moreno Galdó University: Universidad Autònoma de Barcelona Year: 2018
PhD student: Josefa Élida Vázquez Méndez Director/s: Antonio Carrascosa Lezcano, Antonio Carrascosa Lezcano University: Universidad Autònoma de Barcelona Year: 2018
PhD student: Director/s: Maria Clemente Leon University: Universitat Autònoma de Barcelona Year: 2017
PhD student: Nuria Camats Tarruella Director/s: University: Universidad Autònoma de Barcelona Year: 2009
PhD student: Monica Fernandez Cancio, Monica Fernandez Cancio Director/s: University: Universitat de Barcelona Year: 2006
PhD student: Miguel Gussinyé Cañadel Director/s: University: Universidad Autònoma de Barcelona Year: 2005
PhD student: Maria Clemente Leon, Maria Clemente Leon Director/s: University: Universidad Autònoma de Barcelona Year: 2003
The study, in which Vall d'Hebron participates, helps to understand the variability among patients with retinitis pigmentosa.
Es va reconèixer la tasca de més de 70 professionals dedicades a aquesta malaltia pulmonar, tant assistencial com de recerca.
The two studies awarded has been the research for a the ciliary dyskinesia diagnosis led by the VHIR’s Growth and Development Group and the EPISCAN II, in which Dr. Miravitlles has participated.
